213 related articles for article (PubMed ID: 22914589)
1. Risk of death among persons with Alzheimer's disease: a national register-based nested case-control study.
Lönnroos E; Kyyrönen P; Bell JS; van der Cammen TJ; Hartikainen S
J Alzheimers Dis; 2013; 33(1):157-64. PubMed ID: 22914589
[TBL] [Abstract][Full Text] [Related]
2. Incidence of stroke in people with Alzheimer disease: a national register-based approach.
Tolppanen AM; Lavikainen P; Solomon A; Kivipelto M; Soininen H; Hartikainen S
Neurology; 2013 Jan; 80(4):353-8. PubMed ID: 23284063
[TBL] [Abstract][Full Text] [Related]
3. Use of antiepileptic drugs among community-dwelling persons with Alzheimer's disease in Finland.
Bell JS; Lönnroos E; Koivisto AM; Lavikainen P; Laitinen ML; Soininen H; Hartikainen S
J Alzheimers Dis; 2011; 26(2):231-7. PubMed ID: 21593561
[TBL] [Abstract][Full Text] [Related]
4. Incident ischaemic heart disease in persons with Alzheimer's disease in a Finnish nationwide exposure-matched cohort.
Tolppanen AM; Kettunen R; Ahonen R; Soininen H; Hartikainen S
Int J Cardiol; 2013 Dec; 170(2):195-201. PubMed ID: 24200309
[TBL] [Abstract][Full Text] [Related]
5. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
[TBL] [Abstract][Full Text] [Related]
6. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
[TBL] [Abstract][Full Text] [Related]
7. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
8. Burden of Alzheimer's disease-related mortality in the United States, 1999-2008.
Moschetti K; Cummings PL; Sorvillo F; Kuo T
J Am Geriatr Soc; 2012 Aug; 60(8):1509-14. PubMed ID: 22860569
[TBL] [Abstract][Full Text] [Related]
9. 30-Day Mortality after Cardiovascular Events in Persons with or without Alzheimer's Disease.
Heiskanen J; Hartikainen S; Roine RP; Tolppanen AM
J Alzheimers Dis; 2015; 48(1):241-9. PubMed ID: 26401944
[TBL] [Abstract][Full Text] [Related]
10. The effect of comorbidities on survival in persons with Alzheimer's disease: a matched cohort study.
Rajamaki B; Hartikainen S; Tolppanen AM
BMC Geriatr; 2021 Mar; 21(1):173. PubMed ID: 33750334
[TBL] [Abstract][Full Text] [Related]
11. Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study.
Wang KC; Woung LC; Tsai MT; Liu CC; Su YH; Li CY
Neuroepidemiology; 2012; 38(4):237-44. PubMed ID: 22572745
[TBL] [Abstract][Full Text] [Related]
12. Does Alzheimer's disease protect against cancers? A nationwide population-based study.
Ou SM; Lee YJ; Hu YW; Liu CJ; Chen TJ; Fuh JL; Wang SJ
Neuroepidemiology; 2013; 40(1):42-9. PubMed ID: 23075910
[TBL] [Abstract][Full Text] [Related]
13. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study.
Laitinen ML; Lönnroos E; Bell JS; Lavikainen P; Sulkava R; Hartikainen S
Int Psychogeriatr; 2015 Apr; 27(4):669-72. PubMed ID: 25412711
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotype and mortality: findings from the Cache County Study.
Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC;
J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
[TBL] [Abstract][Full Text] [Related]
16. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2014; 41(4):1223-8. PubMed ID: 24787914
[TBL] [Abstract][Full Text] [Related]
18. Dementia-associated mortality at thirteen years in the NEDICES Cohort Study.
Villarejo A; Benito-León J; Trincado R; Posada IJ; Puertas-Martín V; Boix R; Medrano MR; Bermejo-Pareja F
J Alzheimers Dis; 2011; 26(3):543-51. PubMed ID: 21694455
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.
Taipale H; Lampela P; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Alzheimers Dis; 2019; 68(1):127-136. PubMed ID: 30775987
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk of seizures in Alzheimer's disease: A nationwide population-based cohort study.
Cheng CH; Liu CJ; Ou SM; Yeh CM; Chen TJ; Lin YY; Wang SJ
Epilepsy Res; 2015 Sep; 115():63-6. PubMed ID: 26220378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
